Pelthos Therapeutics share price logo

Pelthos Therapeutics

AMEX: PTHS

$22.19

-0.21

(-0.94%)

as on

Pelthos Therapeutics Stock Performance

as on September 28, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $22.21
    $22.92
    downward going graph

    -0.09%

    Downside

    3.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $18.19
    $37.50
    downward going graph

    18.03%

    Downside

    69.00%

    Upside

    downward going graph

Pelthos Therapeutics share price movements today

Previous Close
$22.40
Open
$22.29
Volume
127.6K
Market Cap
$85.0M
Day's Low - High
$22.21 - $22.92
52 Week Low - High
$18.19 - $37.50

Pelthos Therapeutics Historical Returns

1 Month Return
-10.27 %
3 Month Return
-23.56 %
1 Year Return
-34.35 %
3 Year Return
0 %
5 Year Return
0 %

Pelthos Therapeutics Stock Fundamentals & Key Indicators

Check Pelthos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$85.0M

EPS (TTM)

-41.93

Dividend Yield

0.00%

PE Ratio (TTM)

-0.53

Industry PE ratio

-2.64

PEG Ratio

0.0036212701582363847

Return On Equity TTM

-218.94%

Pelthos Therapeutics Stock Valuation

Track how Pelthos Therapeutics P/E has moved over time to understand its valuation trends.

Pelthos Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-11.43x)

December 31, 2021

Industry (-2.64x)

December 31, 2025

Today (-1.35x)

December 31, 2025

Highest (-0.87x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.35x

Pelthos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pelthos Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$85.0MNA-0.5354.72%0.00%
StrongBuy$43.9B615.18%-23.130.00%0.00%
Neutral$79.4B-48.24%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B30.25%18.8284.86%0.47%

Stock Returns calculator for Pelthos Therapeutics Stock including INR - Dollar returns

The Pelthos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Pelthos Therapeutics investment value today

Current value as on today

₹71,036

Returns

-₹28,964

(-28.96%)

Returns from Pelthos Therapeutics Stock

-₹34,349 (-34.35%)

Dollar Impact

₹5,385 (+5.39%)

Analyst Recommendation on Pelthos Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Pelthos Therapeutics. Average target price of $56

Indian Investors' Interest in Pelthos Therapeutics Stock

Search interest for Pelthos Therapeutics Stock has increased by 429% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:429% versus previous 30 day period

Pelthos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
7
9
10
15
Gross Profit
-
-
-
-
-
-
2
4
5
10
Operating Income
-1
-1
-2
-1
-1
-3
-15
-12
-13
-17
EBITDA
-1
-1
-1
-1
-1
-3
-14
-26
-6
-15
Interest Expense
0
0
0
0
0
0
1
1
2
2
Depreciation
-
-
-
-
-
-
0
1
1
1
Income Before Tax
-2
-1
-1
-1
-1
-3
-16
-28
-10
-23
Income Tax Expense
-
-
-
-
-
-
0
-6
-
-
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
-23
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
32.82%
53.24%
51.29%
68.40%

Pelthos Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
16
Gross Profit
0
0
-
-
-
7
Operating Income
-1
0
-2
-6
-7
-32
EBITDA
-
-
-2
-6
-7
-45
Interest Expense
0
0
0
0
0
3
Depreciation
1
0
-
-
-
2
Income Before Tax
0
0
-2
-7
-7
-50
Income Tax Expense
-1
0
-
-
-
-7
Net Income
0
0
-2
-7
-7
-43
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
0.00%
44.24%

Pelthos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-1
-1
-1
-1
-3
-16
-21
-10
-23
Operating Cash Flow
-1
-2
0
0
0
0
-15
-6
-13
-7
Investing Cash Flow
-
-
-
-
-
-
2
-7
0
0
Financing Cash Flow
5
1
0
0
0
0
26
18
27
-
Change in Cash
3
-1
-1
0
0
0
14
3
14
-7

Pelthos Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-2
-7
-7
-43
Operating Cash Flow
-3
-1
-1
0
-5
-22
Investing Cash Flow
-
-
-
-
-
-5
Financing Cash Flow
3
1
1
1
6
45
Change in Cash
-
-
0
0
0
17

Mutual Funds that own Pelthos Therapeutics Stock

Check out the Mutual Funds with significant holdings in Pelthos Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.377033%
91004
Fidelity Concord Street Trust
0.283011%
10835
VANGUARD VALLEY FORGE FUNDS
0.054564%
2089

Global Institutional Holdings in Pelthos Therapeutics

Funds
Holdings
Vanguard
2.46%
VANGUARD INDEX FUNDS
2.38%
Charles Davidson
0.58%
Fidelity Concord Street Trust
0.28%
iShares
0.13%

Insights on Pelthos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 746.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PTHS stock has moved down by -23.6%

About Pelthos Therapeutics

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
OrganisationPelthos Therapeutics
Headquarters4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703, Durham, NC, 27703, US
IndustryBiotechnology
CEOScott Plesha
E-voting on sharesClick here to vote

Key Management of Pelthos Therapeutics

Name

Title

Mr. John M. Gay CPA

CFO, Treasurer & Secretary

Mr. Scott M. Plesha

CEO, President & Director

Mr. Sai Rangarao M.B.A.

Chief Commercial Officer

FAQs

What is Pelthos Therapeutics share price today?

Pelthos Therapeutics share price today is $22.19 as on at the close of the market. Pelthos Therapeutics share today touched a day high of $22.92 and a low of $22.21.

What is the 52 week high and 52 week low for Pelthos Therapeutics share?

Pelthos Therapeutics share touched a 52 week high of $37.50 on and a 52 week low of $18.19 on . Pelthos Therapeutics stock price today i.e. is closed at $22.19,which is 40.83% down from its 52 week high and 21.99% up from its 52 week low.

What is Pelthos Therapeutics's market capitalisation today?

Pelthos Therapeutics market capitalisation is $0.00T as on .

How to invest in Pelthos Therapeutics Stock (PTHS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pelthos Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pelthos Therapeutics Shares that will get you 0.0676 shares as per Pelthos Therapeutics share price of $22.19 per share as on September 28, 2026 at 8:46 am IST.

What is the minimum amount required to buy Pelthos Therapeutics Stock (PTHS) from India?

Indian investors can start investing in Pelthos Therapeutics (PTHS) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Pelthos Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Pelthos Therapeutics share’s latest price of $22.19 as on September 28, 2026 at 8:46 am IST, you will get 0.4507 shares of Pelthos Therapeutics. Learn more about fractional shares .